Results 291 to 300 of about 172,791 (358)

Survivorship Needs and Experiences of Survivors of Head and Neck Cancer in Rural Australia: A Qualitative Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Semi‐structured interviews with 17 rural head and neck cancer survivors revealed six main themes relating to their survivorship needs and experiences: 1) financial impacts, 2) physical effects, 3) psychosocial effects, 4) clinical management, 5) information and support needs, and 6) access.
Poorva Pradhan, Helen Hughes, Ashleigh R. Sharman, Judith Lacey, Patrick Dwyer, Jacques Hill, Kimberley J. Davis, Steven Craig, Raymond Wu, Bruce Ashford, Jenny Mitchell, Jonathan R. Clark, Michael Elliott, Carsten E. Palme, Rebecca L. Venchiarutti   +14 more
wiley   +1 more source

Network pharmacology and gut microbiota insights: unraveling Shenling Baizhu powder's role in psoriasis treatment. [PDF]

Front Pharmacol
Tang B, Zheng X, Luo Q, Li X, Yang Y, Bi Y, Chen Y, Han L, Chen H, Lu C.   +9 more
europepmc   +1 more source

Plasmapheresis and hyperbaric oxygenation in the treatment of psoriasis complicated by polyarthritis

, 2001
V. N. Korobkov, G. G. Slepukha, I. G. Yapparov, А. K. Saetgaraev   +3 more
openalex   +2 more sources

Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease–Patient Knowledge, Perspectives and Practice

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background and Study Aims Patient perspectives on psoriasis as a systemic disease, with its heightened risk of cardiovascular disease (CVD), are unclear. Approaches to cardiovascular risk factor screening and management vary in this cohort. This study aimed to ascertain knowledge, practice and perceptions of patients with respect to psoriasis ...
Annika Smith, Belinda Lai, Clara K. Chow, Sarah Zaman   +3 more
wiley   +1 more source

Nail Psoriasis: A Combined Treatment Using Calcipotriol Cream and Clobetasol Propionate Cream

, 2002
Dimitrios Rigopoulos, D. Ioannides, N. Prastitis, A Katsambas   +3 more
openalex   +1 more source

Using Biologics to Reduce Long‐Term Corticosteroid Use in Pyoderma Gangrenosum: Real‐World Evidence From Two Centres

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a challenging inflammatory skin disorder. While corticosteroids offer a rapid response, their long‐term risks necessitate alternative treatments. Objective To compare the long‐term effectiveness of biologic therapies versus systemic corticosteroids in PG management. Methods A retrospective analysis of 15
R. Cascio Ingurgio, A. Alfano, L. Gargiulo, L. Ibba, A. Narcisi, F. Satgé, M. Stark, A. Costanzo, D. F. Murrell   +8 more
wiley   +1 more source

In Vitro Release of Glycyrrhiza Glabra Extract by a Gel-Based Microneedle Patch for Psoriasis Treatment. [PDF]

Gels
Khorshidian A, Sharifi N, Choupani Kheirabadi F, Rezaei F, Sheikholeslami SA, Ariyannejad A, Esmaeili J, Basati H, Barati A.   +8 more
europepmc   +1 more source

Infliximab for the treatment of severe pustular psoriasis

, 2002
Boni E. Elewski
openalex   +1 more source

Health Equity and Secukinumab for Severe Psoriasis in New Zealand

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background/Objectives The only funded indication in New Zealand between October 2018 and April 2021 for the biologic secukinumab, an interleukin‐17A antibody, was severe psoriasis. This unique period of limited availability of secukinumab allowed the evaluation of who received it and health equity.
Anna Luo, Amanda Oakley, Dug Yeo Han, Paul Jarrett   +3 more
wiley   +1 more source